Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Concord Biotech Legal & Regulatory

Concord Biotech filed a Certificate under SEBI Regulation 74(5) confirming dematerialisation of securities for Q June 2026. The filing is submitted to NSE and BSE.

Source

BSE filing, NSE: CONCORDBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Concord Biotech Ltd: key numbers

Share price
₹1,245.60
Market cap
₹13,031 Cr
Revenue (annual)
₹1,055 Cr
Net profit (annual)
₹260.9 Cr
P/E (TTM)
46.1×Sector 45.9×
Promoter holding
44.09%+0.01% QoQ
FII holding
7.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Concord Biotech Ltd

All →

Other legal & regulatory announcements

All →